Abstract
We assayed apolipoprotein (Apo) A-I levels in re-constituted standard sera, and in serum samples and dried blood samples spotted onto filter-paper, taken from 4 healthy adults. An ELISA method was used to study changes in immunoreactivity after storage at different temperatures, for periods of up to 2 yr. For standard Apo A-I sera, immunoreactivity increased significantly with both time and temperature of storage after reconstitution. Immunoreactivity of Apo A-I in sera of healthy adults was stable on storage at -16 degrees C and -70 degrees C for 43 days, at 4 degrees C for 21 days, and at room temperature for only 10 days, after which there was a considerable increase. Dried blood spot Apo A-I immunoreactivity was also stable at -16 degrees C for at least 43 days, but not at 4 degrees C. Storage at room temperature caused significantly increased immunoreactivity from day 2. These changes could result from temperature and time-dependent structural or compositional changes in high density lipoprotein particles leading to exposure of more Apo A-I antigenic sites. The results define the conditions of time and temperature of storage of samples and standards necessary for Apo A-I assays using ELISA methodology.
References
Jan 1, 1986·Atherosclerosis·J Franzén, G Fex
May 1, 1986·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·P MilthorpY L Marcel
Jun 1, 1987·Pediatric Research·B L BladesD E Wilcken
May 1, 1988·Pediatric Research·B L BladesD E Wilcken
Feb 1, 1987·American Heart Journal·N E Miller
Jul 1, 1987·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·D RobinsonD J Galton
Jul 15, 1985·Clinica Chimica Acta; International Journal of Clinical Chemistry·N P DudmanJ M Aitken
Dec 1, 1974·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·P K Nakane, A Kawaoi
Aug 18, 1983·The New England Journal of Medicine·J J MaciejkoS J Mao
Mar 1, 1984·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J D BrunzellP O Kwiterovich
Nov 11, 1982·The New England Journal of Medicine·V GurewichB Lipinski
Citations
Jun 15, 1992·Clinica Chimica Acta; International Journal of Clinical Chemistry·A GaverL Wong
Dec 31, 1992·Clinica Chimica Acta; International Journal of Clinical Chemistry·S K BangertT J Peters
May 9, 2002·Atherosclerosis·Xing Li WangDavid E L Wilcken
Apr 12, 2000·BJOG : an International Journal of Obstetrics and Gynaecology·J Wang, B Trudinger
Jul 15, 1996·The Journal of Clinical Investigation·X L WangD E Wilcken
May 15, 1992·The American Journal of Cardiology·G SigurdssonN Sigfusson
Jul 12, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Takanari Nakano, Atsuo Nagata
Apr 3, 2014·Drug Testing and Analysis·Abhisheak SharmaJawahar Lal
Dec 1, 1993·Clinical Biochemistry·L BorqueJ del Cura
Jul 3, 2010·Annals of Clinical Biochemistry·N IshimineM Tozuka
Apr 11, 2017·Critical Reviews in Clinical Laboratory Sciences·Sylvain LehmannChristophe Hirtz
May 1, 1994·Circulation·X L WangD E Wilcken
Apr 1, 1996·Circulation·X L WangD E Wilcken
Apr 1, 1997·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·S JahanfarD E Wilcken
Sep 16, 2015·Current Opinion in HIV and AIDS·Kobus HerbstTill Bärnighausen
Jun 7, 2013·Clinical Chemistry and Laboratory Medicine : CCLM·Sylvain LehmannChristophe Hirtz
May 1, 1995·Annals of Clinical Biochemistry·K Evans, M F Laker
Feb 20, 1998·The Medical Journal of Australia·J F LynchD E Wilcken
Feb 1, 2008·Demography·Thomas W McDadeJ Josh Snodgrass